510(k) · Neurology

NuVasive Pulse System

by NuVasive, Incorporated

NuVasive Pulse System is an AI-enabled medical device from NuVasive, Incorporated that the U.S. FDA cleared through 510(k) K180038 on June 29, 2018. Its lead review panel is Neurology and its primary product code is OLO (Orthopedic Stereotaxic Instrument).

See also FDA-cleared AI neurology devices in 2018, all FDA AI clearances in 2018, top neurology AI devices.

Key facts

Submission numberK180038
Pathway510(k)
Date of final decision
Company (FDA list)NuVasive, Incorporated
Lead review panelNeurology
Primary product codeOLO — Orthopedic Stereotaxic Instrument
Applicant (openFDA)Nu Vasive, Incorporated
Applicant locationSan Diego, CA, US
Device classClass 2
Regulation number21 CFR 882.4560
Decision codeSESE
Submission typeTraditional

Source: FDA AI-Enabled Medical Devices list and openFDA.

What this means

A 510(k) is a premarket submission showing the device is substantially equivalent to a legally marketed predicate device. A cleared 510(k) means FDA agreed with that equivalence. NuVasive Pulse System went through this pathway (K180038).

openFDA lists it as a Class 2 device under 21 CFR 882.4560. Class II devices are moderate risk and are subject to general and special controls.

Product code OLO covers 10 devices on the FDA AI list. By decision date, this device is #1 of 10 under that code. NuVasive, Incorporated has 1 AI-enabled device on the list, and the Neurology panel accounts for 73 in total.

Being on this list doesn't describe how well the device works clinically. Check the FDA record for its indications for use.

Similar devices (product code OLO)